[ASS and dipyridamole combination. A decisive contribution to secondary prevention after stroke].
Roman
R
Haberl
D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D000068342:Aspirin, Dipyridamole Drug Combination; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004176:Dipyridamole / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D012008:Recurrence; D020521:Stroke / Q000517:prevention & control*
D000068342:Aspirin, Dipyridamole Drug Combination; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D001241:Aspirin